The following “What We’re Reading” collection is a compilation of recent articles making headlines in HIV and TB news. “Facts” vaginal tenofovir gel study set to launch: The Follow-on African Consortium for Tenofoivr Studies (Facts) study is set to launch in South Africa, following up on the Caprisa 004 trial that found a 59 percent […]
HIV
The following is a guest post by Mitchell Warren of AVAC This year’s annual HIV Vaccine Awareness Day arrives Saturday at a promising and also perilous […]
Tuberculosis
In sub-Saharan Africa where the odds of dying within a year of starting treatment for HIV can still hover close to one-in-10, diagnosing and treating TB […]
Research & Development
A randomized, multi-country clinical trial testing a regimen for treating drug-resistant tuberculosis in less than a year against the up to two-year regimen recommended by the […]
Policy
The following is a guest post by Heather B. Davis, MPH, and Emily A. Bobrow, PhD, MPH, of MEASURE Evaluation Who has a strategic interest in […]